Latest News

Packaging Corporation of America (NYSE:PKG) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 8.2% year on year to $2.14 billion. Its GAAP profit of $2.26 per share was 2% above analysts’ consensus estimates.

Medical technology company Intuitive Surgical (NASDAQ:ISRG) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 19.2% year on year to $2.25 billion. Its non-GAAP profit of $1.81 per share was 4.4% above analysts’ consensus estimates.

Supply chain optimization software maker Manhattan Associates (NASDAQ:MANH) announced better-than-expected revenue in Q1 CY2025, with sales up 3.2% year on year to $262.8 million. The company’s full-year revenue guidance of $1.07 billion at the midpoint came in 0.7% above analysts’ estimates. Its non-GAAP profit of $1.19 per share was 15.7% above analysts’ consensus estimates.

Enterprise workflow software provider Pegasystems (NASDAQ:PEGA) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 44.1% year on year to $475.6 million. Its non-GAAP profit of $1.53 per share was significantly above analysts’ consensus estimates.

Revenues $19.34BN, big miss to estimates of $21.37BN. EPS 27c, missing estimates of 43c.

Water management solutions company Zurn Elkay (NYSE:ZWS) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 4% year on year to $388.8 million. On the other hand, next quarter’s revenue guidance of $422.3 million was less impressive, coming in 0.5% below analysts’ estimates. Its non-GAAP profit of $0.31 per share was 7.1% above analysts’ consensus estimates.

Leaks of handshake progress with Japan and India — even if the ink’s months away — were enough to turbocharge sentiment. Europe, South Korea, Australia, India, the whole friend-shoring club?

Electric vehicle pioneer Tesla (NASDAQ:TSLA) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 9.2% year on year to $19.34 billion. Its GAAP profit of $0.12 per share was 58.4% below analysts’ consensus estimates.

SAP releases its first-quarter results after Tuesday's closing bell. Here's a look at the key figures from the report.

The company spent $14 billion to acquire the developer of this drug, Cobenfy.

Given the company's higher earnings estimates, projections of free cash flow (FCF) and FCF margins, and analysts' price targets, MMM stock could rebound.

Danaher beat Q1 2025 estimates and analysts noted resilience despite macro pressures and China-related headwinds.

The maker of solid-state batteries could be a contrarian play at these levels.

DraftKings (NASDAQ: DKNG) Q1 earnings preview highlights risks from slowed betting growth and regulatory shifts. BofA sees a $30M EBITDA impact from Texas' Jackpocket ban, potentially lowering guidance to $920M. Despite lowered Q1 projections, strong Super Bowl performance keeps full-year outlook intact.

Enphase Energy reports first-quarter revenue of $356.1 million, missing the consensus estimate of $361.43 million.

Home energy technology company Enphase (NASDAQ:ENPH) missed Wall Street’s revenue expectations in Q1 CY2025, but sales rose 35.2% year on year to $356.1 million. Next quarter’s revenue guidance of $360 million underwhelmed, coming in 4% below analysts’ estimates. Its non-GAAP profit of $0.68 per share was 6% below analysts’ consensus estimates.

The U.S. decision to impose tariffs on critical minerals, lithium, cobalt, and rare earths, strikes at the heart of the green tech revolution.

Luxury casino and resort operator Monarch (NASDAQ:MCRI) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 3.1% year on year to $125.4 million. Its GAAP profit of $1.05 per share was 6.1% above analysts’ consensus estimates.